Wernicke-Korsakoff Syndrome


Table of Contents

  1. What is Wernicke-Korsakoff Syndrome?
  2. Thiamine Deficiency: The Core Mechanism
  3. Wernicke's Encephalopathy: The Acute Phase
  4. The Missed Diagnosis Problem
  5. Causes Beyond Alcoholism
  6. Korsakoff's Psychosis: The Chronic Phase
  7. Treatment: The Thiamine Protocol
  8. The Glucose-Before-Thiamine Danger
  9. Prognosis and Recovery
  10. Research Papers
  11. Connections
  12. Featured Videos

Back to Table of Contents


What is Wernicke-Korsakoff Syndrome?

Wernicke-Korsakoff Syndrome (WKS) is a spectrum of brain damage caused by severe thiamine (vitamin B1) deficiency. It has two stages:

The syndrome is named after Carl Wernicke, a German neurologist who described the acute triad in 1881, and Sergei Korsakoff, a Russian psychiatrist who independently characterized the chronic amnesic syndrome in 1887–1891. It took decades for clinicians to recognize they were describing different stages of the same thiamine-deficiency disease.

WKS is severely underdiagnosed. Autopsy studies consistently find that Wernicke's encephalopathy was present but unrecognized in life in over 80% of cases. This diagnostic failure has devastating consequences: untreated Wernicke's progresses to Korsakoff's amnesia, and three-quarters of Korsakoff's patients will never recover meaningful memory function.

Back to Table of Contents

Thiamine Deficiency: The Core Mechanism

Thiamine (vitamin B1) is a water-soluble vitamin that the body cannot synthesize — it must come entirely from food. The brain is exquisitely dependent on thiamine because it is required as a cofactor for three critical enzymes in glucose and energy metabolism:

When thiamine runs out, neurons that depend on aerobic glucose metabolism begin to fail and die. The brain regions most vulnerable are those with the highest metabolic rates and fewest metabolic reserves — the mammillary bodies, the thalamus (especially the dorsomedial thalamic nuclei and pulvinar), the periaqueductal gray matter (surrounding the aqueduct of Sylvius in the brainstem), the floor of the fourth ventricle, and the cerebellar vermis.

The mammillary bodies and mediodorsal thalamus are critical nodes in the Papez circuit — the circuit essential for encoding new episodic memories. Damage here explains Korsakoff's devastating and selective amnesia.

Back to Table of Contents

Wernicke's Encephalopathy: The Acute Phase

The classic triad of Wernicke's encephalopathy consists of:

  1. Confusion / altered mental status: A global confusional state — patients appear disoriented, inattentive, quietly delirious. They may be lethargic or stuporous. Not psychotic agitation — quiet confusion is more typical.
  2. Ophthalmoplegia: Eye movement abnormalities from damage to the oculomotor nuclei in the brainstem. Most common finding is bilateral lateral rectus palsy (sixth cranial nerve, causing inability to look outward — presenting as horizontal diplopia and medial deviation of the eyes). Nystagmus is also prominent — typically horizontal or horizontal-rotatory. In severe cases, conjugate gaze palsy occurs.
  3. Ataxia: Wide-based, unsteady gait with difficulty walking (similar to alcoholic cerebellar degeneration). Many patients cannot walk at all; truncal ataxia may prevent sitting without support.

Critical Teaching Point: The Triad Is Rarely Complete

Only approximately 10–16% of patients with Wernicke's encephalopathy present with all three features of the triad. This is the single most important clinical fact about this condition. Studies of autopsy-proven cases consistently show that most patients had only one or two features — often just confusion alone, or confusion with nystagmus. The absence of the full triad should never be used to exclude the diagnosis in a patient at risk.

The European Federation of Neurological Societies (EFNS) operationalized this in diagnostic criteria requiring only 2 of 4 criteria (dietary deficiencies, clinical features of either encephalopathy/eye signs/cerebellar features/memory impairment) to initiate treatment — explicitly designed to capture partial presentations.

Back to Table of Contents

The Missed Diagnosis Problem

WKS is tragically underdiagnosed because of several converging factors:

The consequences of missed diagnosis are severe: untreated Wernicke's has a mortality of approximately 10–20%, and survivors frequently develop permanent Korsakoff's amnesia. The treatment (intravenous thiamine) is cheap, safe, and rapidly effective if given early. The risk-benefit calculation overwhelmingly favors empiric treatment in any at-risk patient with altered mental status.

Back to Table of Contents

Causes Beyond Alcoholism

While chronic alcoholism accounts for the majority of WKS cases in Western countries (due to poor diet, impaired thiamine absorption, and increased metabolic demand), thiamine deficiency can occur from many causes. Any condition causing inadequate thiamine intake, absorption, or increased demand can precipitate Wernicke's encephalopathy:

Back to Table of Contents

Korsakoff's Psychosis: The Chronic Phase

Korsakoff's syndrome (also called Korsakoff's amnesic syndrome or Korsakoff's psychosis) is the chronic amnesic state that follows untreated or inadequately treated Wernicke's encephalopathy. It results from permanent damage — primarily to the mammillary bodies and the mediodorsal nucleus of the thalamus.

Core Features

MRI Findings

The characteristic finding is mammillary body atrophy — visible on standard brain MRI as shrunken, hypointense mammillary bodies on T1-weighted sequences. In acute Wernicke's, the mammillary bodies may show T1 hyperintensity (petechial hemorrhage) and T2/FLAIR signal change. Thalamic atrophy (especially mediodorsal nuclei) is also seen. These MRI changes confirm the anatomical substrate of Korsakoff's amnesia.

Back to Table of Contents

Treatment: The Thiamine Protocol

The treatment for Wernicke's encephalopathy is high-dose intravenous thiamine, given urgently. Oral thiamine is insufficient in acute WKS because absorption is impaired in malnourished and alcoholic patients, and the therapeutic window requires rapid CNS delivery.

Recommended Dosing (Acute Wernicke's Encephalopathy)

This is NOT a condition to treat with oral thiamine or low-dose IV thiamine. Earlier protocols used 100 mg IV thiamine — now known to be inadequate. A 2013 Cochrane review found the evidence for specific dose insufficient, but expert consensus and the EFNS have moved firmly toward 500 mg IV TID as standard of care for suspected acute Wernicke's.

What NOT to Do

Back to Table of Contents

The Glucose-Before-Thiamine Danger

One of the most important clinical rules in emergency medicine and neurology is:

Give thiamine BEFORE glucose in any patient at risk of Wernicke's encephalopathy.

This rule exists because of the fundamental biochemistry of thiamine deficiency. When glucose is administered to a patient with borderline or frank thiamine deficiency, it dramatically increases the metabolic demand for thiamine as a cofactor (thiamine is essential for all three key steps in glucose metabolism via pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase). In a patient whose thiamine stores are already depleted, this sudden increase in demand can acutely exhaust remaining thiamine reserves and precipitate — or dramatically worsen — Wernicke's encephalopathy within hours.

This is not theoretical. Case reports and case series document acute Wernicke's encephalopathy precipitated by glucose infusion in malnourished patients presenting with hypoglycemia, in patients receiving refeeding, and in hyperemesis patients given antiemetics and IV fluids containing dextrose without thiamine. The lesson: whenever a malnourished, alcoholic, or otherwise at-risk patient presents and you plan to give IV fluids containing glucose, give 100–500 mg IV thiamine first.

The practical protocol for any at-risk patient arriving in the emergency department (alcoholic, malnourished, hyperemesis, post-bariatric) with confusion or altered mental status: thiamine IV → then glucose → then further assessment.

Back to Table of Contents

Prognosis and Recovery

Prognosis depends critically on how quickly treatment is initiated and how much structural damage has already occurred.

Wernicke's Encephalopathy — If Treated Promptly

Korsakoff's Syndrome — Long-Term Prognosis

The Goal: Prevention

Given the catastrophic and largely irreversible outcome of established Korsakoff's syndrome, prevention is paramount. This means:

Back to Table of Contents


Research Papers

Curated PubMed topic searches on Wernicke-Korsakoff syndrome. Each link opens a live PubMed query so the result set stays current as new studies are indexed.

  1. PubMed: Wernicke encephalopathy thiamine deficiency diagnosis
  2. PubMed: Wernicke encephalopathy clinical triad missed diagnosis
  3. PubMed: Korsakoff syndrome mammillary bodies amnesia
  4. PubMed: Thiamine dose intravenous Wernicke treatment
  5. PubMed: Wernicke encephalopathy non-alcoholic bariatric surgery
  6. PubMed: Wernicke encephalopathy hyperemesis gravidarum
  7. PubMed: Glucose thiamine deficiency precipitate Wernicke
  8. PubMed: Confabulation Korsakoff syndrome memory neuroscience
  9. PubMed: Wernicke encephalopathy MRI mammillary bodies thalamus
  10. PubMed: Korsakoff syndrome prognosis recovery long-term outcome
  11. PubMed: Thiamine deficiency dialysis renal failure supplementation
  12. PubMed: Wernicke encephalopathy cancer chemotherapy malnutrition

Back to Table of Contents


Connections

Back to Table of Contents